Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 September 2021 | Story Ruan Bruwer | Photo Varsity Sports
Thabo Lesibe, captain of the UFS team, on his way to score the winning goal against Tuks in the semi-final of Varsity Football.


To finish his very last match for the Kovsies as the winning captain of Varsity Football would mean the world to him, says Thabo Lesibe.

The University of the Free State (UFS) men’s team reached the final of Varsity Football for the very first time. They will face the University of Johannesburg (UJ) in Pretoria on Monday, 4 October 2021. The match gets underway at 19:15.

The UFS booked their spot in the final thanks to a 2-1 victory over Tuks in Tuesday’s semi-final.

“It would certainly be the cherry on the cake and the best possible way for me to bow out,” Lesibe said. He is in his final year of study for a Bachelor of Laws, which he started in 2015. Lesibe was responsible for scoring the winning goal from a penalty against Tuks. 

On their way to the semi-finals, Kovsies also defeated the University of KwaZulu-Natal, Tuks, and Wits and drew against the North-West University (NWU), Tshwane University of Technology, and the Vaal University of Technology. Their only loss was against UJ (0-1).

“It feels amazing to reach the final. We are all very excited. There is a strong unity in the camp and a common belief. We are playing for something far greater than the eye can see,” the captain said.

According to Lesibe, the pain of 2019 has been a motivator for them in 2021. In the 2019 Varsity Football competition, Kovsies and NWU finished level on log points and with the same goal difference, but NWU progressed to the semis courtesy of scoring nine goals to the UFS’s eight in the group stage.

“When it gets tough on the playing field, we remind ourselves of that disappointment which propelled us, as we did not want to experience that pain again.”

Prof Francis Petersen, Rector and Vice-Chancellor of the UFS, congratulated the team on a successful Varsity Football season. 
“This is a great achievement for the team as well as for the university. You have shown once again that the University of the Free State is home to top sports stars. Following the victory of our Kovsie Netball team, we look forward to adding another title to our sporting achievements this year.”

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept